Who Is Dr. Heidi Overton? Trump's FDA Nominee Once Stood By Him Over False Autism-Vaccine Claim

Dr Heidi Overton, a White House health adviser who stood beside Donald Trump as he questioned established vaccine science, has been nominated to lead the US Food and Drug Administration, putting her record on immunisations and public health under immediate scrutiny.

As a medical doctor and current deputy director of the White House Domestic Policy Council, Dr Overton has emerged as a key figure in advancing the administration's second-term health policies.

Her nomination brings immediate scrutiny to her recent public appearances, most notably when she stood beside the president in the Oval Office as he falsely suggested the timing of childhood vaccinations could influence autism rates.

Decades of rigorous scientific studies have firmly established there is no such link, yet Overton remained present as the administration ordered the splitting of the measles, mumps and rubella vaccine against widespread medical advice.

Dr Heidi Overton Faces a Divided Senate

In May, former FDA chief Dr Marty Makary abruptly resigned, leaving behind an agency managing internal disagreements and a backlog of unresolved policy battles over ultra-processed foods, antidepressants and Covid-19 immunisations.

Navigating the confirmation process will force the FDA nominee to confront a narrowly Republican-led Senate.

She will face questioning from the Senate Health, Education, Labor and Pensions Committee, chaired by Republican Senator Bill Cassidy.

The Louisiana physician has been a critic of recent efforts by the president to question established vaccination protocols.

Democratic opposition is already mounting, with Washington Senator Patty Murray posting on social media that Overton is a 'far-right, anti-abortion extremist' who 'has no business leading the FDA'.

Overton built her credentials at the University of New Mexico for medical school before earning a doctoral degree in clinical investigation from Johns Hopkins University. Prior to her White House tenure, she served as chief policy officer at the America First Policy Institute.

Trump recently took to his Truth Social platform to describe 'Dr Heidi' as a highly respected 'rockstar' who would secure faster cures, lower drug prices and immediate victories for the 'Make America Healthy Again' movement led by Health Secretary Robert F Kennedy Jr.

FDA Nominee Inherits a Complex Web of Policies

Kennedy himself praised the nominee on X, citing her professionalism, discipline and commitment to the American people. The FDA nominee is stepping into an environment defined by competing ideological pressures.

Traditional conservatives are pushing for sweeping deregulation, while Kennedy maintains a strongly anti-corporate posture.

The agency she aims to lead is currently managing the sudden departures of several senior scientific officials. Dr Vinay Prasad, the vaccine and biotech chief, resigned in April amid criticism from pharmaceutical companies and investors.

Dr Tracy Beth Hoeg, who monitored the safety of widely used therapies, was subsequently replaced as acting drug centre director. Makary departed following a dispute over flavoured electronic cigarettes, during which career scientists expressed concerns about bypassed regulatory procedures.

Public Health Crises and Culture Wars Await

Beyond Washington politics, the immediate reality of public health awaits the incoming leader. The agency is actively investigating a cyclospora outbreak linked to tainted iceberg lettuce and a multistate salmonella outbreak tied to jalapeño peppers.

Overton must also navigate looming decisions over whether to restrict access to abortion pills prescribed online, a move anticipated by conservative activists. At the same time, federal health advisers selected by Kennedy are pushing to ease access to untested wellness peptides.

It remains to be seen whether a new commissioner can balance the demands of the White House with the established scientific protocols of the agency.